SCHEMBL6432268

SCHEMBL6432268

NC(=O)/C(=C\c1ccccc1)Cc1ccccc1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.73
CYP2C9 P11712 1/20 0.73
MCL1 Q07820 1/20 0.47
RECQL P46063 1/20 0.47
CES1 P23141 2/20 0.47
CES2 O00748 1/20 0.47
AKR1B1 P15121 1/20 0.47
HIF1A Q16665 1/20 0.43
MME P08473 2/20 0.41
CNR2 P34972 1/20 0.41
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
KDM4E B2RXH2 1/20 0.41
GAA P10253 1/20 0.41
MAPT P10636 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
HDAC8 Q9BY41 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41
AKR1C3 P42330 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4776145 1.00 CYP3A4 (0.73) CYP3A4CYP2C9MCL1RECQLCES1
SCHEMBL453849 0.85 CYP3A4 (0.79) CYP3A4CYP2C9RECQLCES1CES2
SCHEMBL58023 0.85 CYP3A4 (1.00) CYP3A4CYP2C9RECQLCES1CES2
SCHEMBL453850 0.85 CYP3A4 (0.79) CYP3A4CYP2C9RECQLCES1CES2
SCHEMBL58024 0.85 CYP3A4 (1.00) CYP3A4CYP2C9RECQLCES1CES2
SCHEMBL2957009 0.83 CYP3A4 (0.96) CYP3A4CYP2C9RECQLCES1CES2
SCHEMBL28332697 0.82 CYP3A4 (0.53) CYP3A4CYP2C9MCL1RECQLMME
SCHEMBL28263544 0.82 CYP3A4 (0.54) CYP3A4CYP2C9MCL1RECQLNPC1
SCHEMBL22147 0.81 CYP3A4 (0.73) CYP3A4CYP2C9RECQLCES1CES2
SCHEMBL30814247 0.81 CYP3A4 (0.79) CYP3A4CYP2C9RECQLCES1CES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1556032-A1 AGENT FOR PREVENTING OR TREATING NEUROPATHY Takeda Pharmaceutical Company Limited (JP) 2005-07-27 EP disclosed
WO-2004039365-A1 AGENT FOR PREVENTING OR TREATING NEUROPATHY TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-05-13 WO disclosed